Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

MLA

Liu M, et al. “Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients.” Journal of Hepatocellular Carcinoma, vol. ume 7, Oct. 2020, pp. 219–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6253bd3315a74a16bb961e7aacbacd10&authtype=sso&custid=ns315887.

APA

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, & Niu J. (2020). Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients. Journal of Hepatocellular Carcinoma, ume 7, 219–232.

Chicago

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, et al. 2020. “Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients.” Journal of Hepatocellular Carcinoma ume 7 (October): 219–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6253bd3315a74a16bb961e7aacbacd10&authtype=sso&custid=ns315887.